These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 7493058)

  • 1. Perfluorocarbons in the twenty-first century: clinical applications as transfusion alternatives.
    Spence RK
    Artif Cells Blood Substit Immobil Biotechnol; 1995; 23(3):367-80. PubMed ID: 7493058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artificial oxygen carriers as a possible alternative to red cells in clinical practice.
    Barbosa FT; Jucá MJ; Castro AA; Duarte JL; Barbosa LT
    Sao Paulo Med J; 2009 May; 127(2):97-100. PubMed ID: 19597685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood substitutes and oxygen therapeutics: an overview and current status.
    Jahr JS; Nesargi SB; Lewis K; Johnson C
    Am J Ther; 2002; 9(5):437-43. PubMed ID: 12237737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perfluorocarbons as blood substitutes: the early years. Experience with Fluosol DA-20% in the 1980s.
    Spence RK; Norcross ED; Costabile J; McCoy S; Cernaianu AC; Alexander JB; Pello MJ; Atabek U; Camishion RC
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(4):955-63. PubMed ID: 7849967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute normovolemic hemodilution.
    Monk TG
    Surg Infect (Larchmt); 2005; 6 Suppl 1():S9-15. PubMed ID: 19284358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Finding alternatives to blood transfusion.
    Kirschman RA
    Holist Nurs Pract; 2004; 18(6):277-81; quiz 282-3. PubMed ID: 15624274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of perftoran emulsion to decrease allogeneic blood transfusion in cardiac surgery: clinical trial.
    Verdin-Vasquez RC; Zepeda-Perez C; Ferra-Ferrer R; Chavez-Negrete A; Contreras F; Barroso-Aranda J
    Artif Cells Blood Substit Immobil Biotechnol; 2006; 34(4):433-54. PubMed ID: 16818416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perflubron emulsion delays blood transfusions in orthopedic surgery. European Perflubron Emulsion Study Group.
    Spahn DR; van Brempt R; Theilmeier G; Reibold JP; Welte M; Heinzerling H; Birck KM; Keipert PE; Messmer K; Heinzerling H; Birck KM; Keipert PE; Messmer K
    Anesthesiology; 1999 Nov; 91(5):1195-208. PubMed ID: 10551568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxygen carriers as blood substitutes. Past, present, and future.
    Goodnough LT; Scott MG; Monk TG
    Clin Orthop Relat Res; 1998 Dec; (357):89-100. PubMed ID: 9917705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospectus. Future trends in transfusion.
    Manner PA; Rubash HE; Herndon JH
    Clin Orthop Relat Res; 1998 Dec; (357):101-15. PubMed ID: 9917706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternatives to allogeneic blood transfusions.
    Mulier M
    Acta Anaesthesiol Belg; 2002; 53(2):119-24. PubMed ID: 12146099
    [No Abstract]   [Full Text] [Related]  

  • 12. Oxygen carriers ("blood substitutes").
    Topfer LA; Hailey D
    Issues Emerg Health Technol; 2001 Jul; (21):1-6. PubMed ID: 11776287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current status of oxygen carriers ('blood substitutes'): 2006.
    Winslow RM
    Vox Sang; 2006 Aug; 91(2):102-10. PubMed ID: 16907870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perfluorocarbons: future clinical possibilities.
    Clark MC; Weiman DS; Pate JW; Gir S
    J Invest Surg; 1997; 10(6):357-65. PubMed ID: 9654392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood Substitutes and Oxygen Therapeutics: A Review.
    Jahr JS; Guinn NR; Lowery DR; Shore-Lesserson L; Shander A
    Anesth Analg; 2021 Jan; 132(1):119-129. PubMed ID: 30925560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perfluorocarbon-based oxygen delivery.
    Riess JG
    Artif Cells Blood Substit Immobil Biotechnol; 2006; 34(6):567-80. PubMed ID: 17090429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perfluorochemical "red blood cell substitutes": the continued search for an indication.
    Tremper KK
    Anesthesiology; 2002 Dec; 97(6):1333-4. PubMed ID: 12459656
    [No Abstract]   [Full Text] [Related]  

  • 18. Alternatives to blood in the 21st century.
    Cohn SM
    Crit Care; 2004; 8 Suppl 2(Suppl 2):S15-7. PubMed ID: 15196316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxygen therapeutics: perfluorocarbons and blood substitute safety.
    Cohn CS; Cushing MM
    Crit Care Clin; 2009 Apr; 25(2):399-414, Table of Contents. PubMed ID: 19341916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Artificial blood in the future].
    Charles E
    Rev Infirm; 1999 Sep; (52):42-3. PubMed ID: 10723430
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.